Correlation Between Bristol-Myers Squibb and Merck

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and Merck at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and Merck into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol-Myers Squibb and Merck Company, you can compare the effects of market volatilities on Bristol-Myers Squibb and Merck and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of Merck. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and Merck.

Diversification Opportunities for Bristol-Myers Squibb and Merck

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Bristol-Myers and Merck is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Bristol-Myers Squibb and Merck Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck Company and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol-Myers Squibb are associated (or correlated) with Merck. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck Company has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and Merck go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and Merck

Considering the 90-day investment horizon Bristol-Myers Squibb is expected to generate 1.12 times more return on investment than Merck. However, Bristol-Myers Squibb is 1.12 times more volatile than Merck Company. It trades about 0.14 of its potential returns per unit of risk. Merck Company is currently generating about 0.09 per unit of risk. If you would invest  6,865  in Bristol-Myers Squibb on July 7, 2022 and sell it today you would earn a total of  280.00  from holding Bristol-Myers Squibb or generate 4.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Bristol-Myers Squibb  vs.  Merck Company

 Performance (%) 
       Timeline  
Bristol-Myers Squibb 
Bristol-Myers Performance
0 of 100
Over the last 90 days Bristol-Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Bristol-Myers Squibb is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Bristol-Myers Price Channel

Merck Company 
Merck Performance
0 of 100
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Merck is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Merck Price Channel

Bristol-Myers Squibb and Merck Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol-Myers Squibb and Merck

The main advantage of trading using opposite Bristol-Myers Squibb and Merck positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, Merck can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will offset losses from the drop in Merck's long position.
Bristol-Myers Squibb vs. Amazon Inc
The idea behind Bristol-Myers Squibb and Merck Company pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Merck vs. Amazon Inc
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go